Norwalk, Connecticut-based FactSet Research Systems Inc. (FDS) operates as a financial data and analytics platform and enterprise solutions provider for the investment community. Valued at a market capitalization of $7.9 billion, the company offers data, products, and analytical applications, as well as workstations, portfolio analytics, and enterprise data solutions, along with managed services to support data, performance, and risk.
FDS is expected to release its Q3 2026 earnings on Wednesday, July 1, before the market opens. Ahead of the event, analysts expect the company’s EPS to be $4.44 on a diluted basis, up 4% from $4.27 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in two of its last four quarters, while missing on two occasions.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For fiscal 2026, analysts project the company’s EPS to be $17.66, up 4% from $16.98 in fiscal 2025. Moreover, its EPS is expected to rise by roughly 10.7% year over year (YoY) to $19.5 in fiscal 2027.
www.barchart.com FDS stock has declined 50.1% over the past 52 weeks, underperforming the S&P 500 Index’s ($SPX) 22.2% rise and the State Street Financial Select Sector SPDR ETF’s (XLF) 6% rise during the same time frame.
www.barchart.com On Mar. 31, FDS stock rose 6.1% following the release of its Q2 2026 earnings. The company’s revenue for the quarter came in at $611 million, surpassing Wall Street’s estimates. Moreover, its adjusted EPS amounted to $4.46, also coming in on top of the Street’s forecasts. FactSet expects full-year earnings in the range of $17.25 to $17.75 per share, with revenue in the range of $2.45 billion to $2.47 billion.
Analysts are skeptical about FDS, with the stock having a “Hold” rating overall. Among the 19 analysts covering the stock, three are recommending a “Strong Buy,” 10 suggest a “Hold,” one suggests a “Moderate Sell,” and five suggest a “Strong Sell.” FDS’ average analyst price target of $255.69 offers a 17.2% upside potential.
On the date of publication, Aritra Gangopadhyay did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
How to Buy Merck Stock for a 10% Discount or Achieve an 11% Annual Return Nasdaq Futures Gain After Brutal Tech Selloff, Micron Earnings in Focus AMEN Properties Just Announced a 25% Dividend Increase. What This Means for the High-Yield Royalty Stock. The $200 Million Reason AMC Stock Is Down Today